Eversept Partners LP Buys New Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Eversept Partners LP bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 139,656 shares of the medical instruments supplier's stock, valued at approximately $2,651,000. Eversept Partners LP owned about 0.07% of DENTSPLY SIRONA at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XRAY. Barclays PLC increased its position in shares of DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after purchasing an additional 54,920 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in DENTSPLY SIRONA during the 3rd quarter worth approximately $261,000. Tidal Investments LLC acquired a new position in DENTSPLY SIRONA during the third quarter worth approximately $602,000. Synovus Financial Corp purchased a new stake in DENTSPLY SIRONA in the third quarter valued at approximately $240,000. Finally, JPMorgan Chase & Co. boosted its holdings in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction on Monday, March 3rd. The shares were bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.52% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Price Performance

XRAY stock traded up $0.04 during trading on Friday, reaching $13.75. 2,078,513 shares of the company were exchanged, compared to its average volume of 2,973,073. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock's 50 day moving average price is $15.09 and its 200 day moving average price is $18.25. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $31.00. The company has a market cap of $2.74 billion, a P/E ratio of -6.64, a PEG ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.65%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

Analyst Upgrades and Downgrades

XRAY has been the subject of several research reports. Wells Fargo & Company reduced their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their target price for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Barrington Research lowered their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research note on Tuesday, April 15th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Thirteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $22.58.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.